Clinical Trials Logo

Clinical Trial Summary

Remote ischaemic conditioning (RIC) is known to reduce infarct size post MI when used in the peri/immediate post infarct period. However little is known as to the effect of repeated remote conditioning post-MI (Myocardial Infarction) on not only infarct size, but also on ventricular remodeling and ultimately cardiac failure. In this phase II first in man trial, the investigators intend to carry out daily remote ischaemic conditioning in post MI patients. The principal hypothesis is that RIC applied on a daily basis for 4 weeks following a heart attack improves the ejection fraction at 4 months as assessed by cardiac magnetic resonance imaging.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01664611
Study type Interventional
Source University of Leicester
Contact
Status Completed
Phase N/A
Start date September 26, 2012
Completion date October 30, 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT04637555 - Open-label Extension Study for CLCZ696G2301 (PARADISE-MI) Phase 3
Completed NCT00605631 - The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study N/A